期刊文献+

抗hTNF-α中和抗体识别表位的筛选和鉴定

Screening and identification of anti- hTNF-α monoclonal antibody recognized hTNF-α epitopes from 7^(TM) phage display peptide library
下载PDF
导出
摘要 目的:对噬菌体随机线性7肽库进行筛选,得到能与抗hTNF -α中和抗体特异性结合的表位肽. 方法: 以抗hT NF- α中和抗体为靶,筛选噬菌体线性7肽库,双夹心ELISA,竞争抑制ELISA及MAP点杂交鉴定阳性噬菌体克隆. 结果:经3轮筛选后随机挑取50个噬菌体克隆,经ELISA检测其中15个克隆显示与抗hTNF- α抗体有较强的结合能力,DNA测序结果得到的结构相似群为:WTFKMQP, WPFKMSP, WPYK MIP和WNYKMLP, 竞争性ELISA结果显示四个序列均能与TNF竞争性结合抗hTNF -αmAb,MAP点杂交结果显示筛选得到的多肽是能与抗hTNF -α抗体特异性结合的多肽. 结论:列具有很高的同源性,并能与抗hTNF -α中和抗体特异性结合,为hTNF -α相关多肽疫苗的研究提供依据. AIM: To screen out short peptide epitopes from 7 TM phage display peptide library, which are capable of combining with anti-hTNF-α monoclonal antibody. METHODS: The epitopes of human tumor necrosis factor were screened from 7 TM phage display peptide library by using anti-hTNF-α antibody as target protein and identified by sandwich ELISA and dot-blot. RESULTS: After 3 rounds of screening, 15 of the 50 phage clones were identified as positive clones, which bound to the anti-hTNF-α antibody. The amino acid sequences of the positive clones were WTFKMQP, WPFKMSP, WPYKMIP and WNYKMLP. CONCLUSION: The framework of the screened epitopes is similar and the epitopes can specifically bind to the anti-hTNF-α antibody, which provides the basis for the development of short peptide vaccines.
出处 《第四军医大学学报》 北大核心 2005年第7期607-609,共3页 Journal of the Fourth Military Medical University
关键词 肿瘤坏死因子 噬茵体随机肽库 抗体 表位 tumor necrosis factor phage display peptide library antibodies epitope
  • 相关文献

参考文献8

  • 1Sandborn WJ. Optimizing anti-tumor necrosis factor strategies in inflammatory bowel disease [R]. Curr Gastroenterol Rep, 2003 ;5 (6):501 - 505.
  • 2Drosou A, Kirsner RS, Welsh E, et al. Use of infliximab, an antitumor necrosis alpha antibody, for inflammatory dermatoses [J]. J Cutan Med Surg, 2003 ;7 (5) :382 -386.
  • 3Fleischmann R, Shealy D. Developing a new generation of TNF-αantagonists for the treatment of rheumatoid arthritis[J]. Mol Interv,2003;3(6) :310 -318.
  • 4Bang LM, Keating GM. Adalimumab: A review of its use in rheumatoid arthritis[J]. BioDrugs, 2004;18(2) :121 - 139.
  • 5Toussirot E, Wendling D. The use of TNF-α blocking agents in rheumatoid arthritis: An overview [J]. Expert Opin Pharmacother,2004;5(3) :581 -594.
  • 6den Broeder AA, Assmann KJ, van Riel PL, et al. Nephrotic syndrome as a complication of anti-TNF-α in a patient with rheumatoid arthtitis[J]. Neth J Med, 2003 ;61 (4) :137 - 141.
  • 7Louis M, Rauch J, Armstrong M, et al. Induction of autoantibodies during prolonged treatment with infliximab [J]. J Rheumatol, 2003;30 (12) :2557 - 2562.
  • 8Wiesehan K, Willbold D. Mirror-image phage display: Aiming at the mirror[J]. Chembiochem, 2003; 4(9):811 -815.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部